Management team

Patrik Dahlen, Chief Executive Officer

Patrik Dahlen holds a MSc in Biochemistry from Åbo Akademi University and a PhD in Biochemistry from Turku University. He brings over 30 years of senior level experience as an executive in the life science and diagnostics industry. Patrik contributes with broad international experience in Europe and the US with substantial diagnostic and international industry expertise. As Chief Executive Officer of Dako, Patrik, carried out a major strategic repositioning of the company as a leading supplier of cancer diagnostics. As President of Life Sciences at the American company Perkin Elmer, Patrik was instrumental in building the company’s diagnostic business with a niche focus on diagnostic systems for neonatal and prenatal screening. He has led organizations ranging from 10 to 2000 people based in Finland, Denmark, UK and USA and has considerable public company experience. Additional experience includes CEO, SSI Diagnostic, Denmark, CEO, Immunodiagnostic Systems (IDS), UK; CEO NeuroSearch, Denmark.

Current assignments: Chairman of the Board of Visiopharm and Advalight. Board member of SSI Diagnostica.

Previous assignments (last five years): Board Member of LEO Pharma and Immunovia AB.

Rolf Ehrnström, Chief Scientific Officer

Rolf Ehrnström holds an M.Sc. (Eng.) in biochemistry and biotechnology from the Royal Institute of Technology, Stockholm. He is the proprietor of Reomics AB and an Independent Partner of Ventac-Partners. He has long-term experience of managing research and has served as Chief Scientific Officer of Dako/Agilent and Gyros AB. He also has experience as Science Director of Amersham Bioscience and Pharmacia Biotech.

Current assignments: Board member of Reomics AB, Gradientech AB, Scandinavian Chemotech AB and Fluimedix A/S Danmark.

Previous assignments (past five years): Member of the Nomination Committee of Idogen AB.

Hans Liljenborg, Chief Financial Officer

Hans Liljenborg is a graduate of specialist education in business administration and mathematics from Lund University. He has long-term experience as a Finance Director of growing, global medical device companies. He has served as Finance Director of Physio Control Inc./Jolife AB and Finance Manager of Vivoline Medical AB, which was listed on Nasdaq First North in March 2015. He is also proprietor of his own accounting firm.

Current assignments: Board member of ADAYS AB. Deputy director of Entreprenörskompetens i Lund AB, and IES Interactive Executive Search AB. Auditor of the cooperative Byns Förskola Ekonomisk förening. Partner in Prosperus.

Previous assignments (past five years): Executive positions at E-vård Sverige AB, Jolife AB, QuickCool AB and Vivoline Medical AB. Auditor of Bostadsrättsföreningen Långgårdsgatan 17, deputy director of Gantus Training AB and Solbacka Trading.

Laura Chirica, Chief Commercial Officer

Laura Chirica holds an M.Sc. in biochemistry from Umeå University and a Ph.D. in biochemistry from Umeå University. With over 15 years’ experience of business executive positions in the life science and diagnostics sectors, she brings extensive knowledge of business, organizational and strategic development, as well as sales, tactical marketing, product management and product support. She has led and restructured multinational sales and marketing organizations, managed business development, the integration of acquired companies, and developed brands and marketing communication platforms. Much of her experience has been gathered from leadership of multinational management teams and organizations in Scandinavia, Europe, the US and Asia. Previous positions include: VP of Sales and Marketing for Euro Diagnostica AB, Director of Purification Technologies for Europe Sartorius Stedim, Global Marketing Director of Dako A/S and Global Marketing Program Manager of GE Healthcare.

Current assignments: Board member of SenzaGen AB.

Previous assignments (past five years): Executive position at Euro-Diagnostica AB.

Michael Pettigrew, Senior VP Sales North America

Michael Pettigrew has a Bachelor of Science in biologi at Fairleigh Dickinson University. He brings over 30 years of experience and has focused his extensive global expertise in the management of marketing & sales, business and strategic account development, licensing, mergers & acquisition, and commercial technology platform development. While he was at Thermo Fisher Scientific, he managed large regional based sales teams (USA, Canada, Latin America, and South America) by providing sales, technical support, and customer support. Prior to Thermo Fisher Scientific, Michael was the Vice President of Corporate Development at Magellan Biosciences, where he was focused on M&A and licensing. Prior to that, Michael held positions at GE Healthcare (Vice President, Sales), Amersham (Vice President, Genomics), and Pharmacia (Director of Marketing, North America).

Current assignments: None.

Previous assignments (past five years): VP Sales Americas Thermo Fisher Scientific.

Hans Christian Pedersen, VP of Strategy & Business Development

Hans Christian Pedersen holds a Master’s Degree in Molecular Biology from the University of Copenhagen. He has over 18 years’ experience in the sector working with drug development, antibody development, breast cancer research, complementary diagnostic development, IVD global marketing, scientific affairs and business development. He has extensive experience in both development and commercialization of diagnostic tests and has been involved in building and starting strategic partnerships with global pharma partners. Previous positions include Director of Business Development, Unilabs, Director of Scientific Affairs, Agilent Technologies, Research Manager, Companion Diagnostics, Dako, Global Product Manager, Dako.

Current assignments: None

Previous assignments (past five years): Director of Business Development, Unilabs; Director of Scientific Affairs, Agilent Technologies and Head of Companion Diagnostics and IHC reagents, Agilent Technologies.

Linda Mellby, VP Research & Development

Linda Mellby holds a master’s degree in chemical engineering and a doctorate in immune technology from the Department of Immune Technology from Lund University. Linda Mellby has more than seven years of experience in leading research and development at Immunovia. The work has included bioinformatics-assisted biomarker identification, platform and technology development, clinical trials and the development of blood-based diagnostic testing for pancreatic cancer. Linda has over 15 years of experience in antibody micromatography technology and clinical applications in cancer proteomics.

Current assignments: None.

Previous assignments (past five years): None.

Lotta Blomgren, Operations Director

Lotta Blomgren holds a MSc in Chemical Engineering from Lund University, Sweden. Lotta has more than 30 years’ experience within the life science and diagnostics industry, whereof 15 years in leading positions. She contributes with extensive experience from leading manufacturing, quality control and logistics teams, as well as managing transfer of new products from development to commercial scale. Her track record includes strategic reorganizations of international manufacturing networks, managing people and project portfolios, as well as due diligence of potential acquirement of new companies and Contract Manufacturing (CMO).
Previous positions include VP Technical Operations at Euro Diagnostica AB, Head of Supply Chain Bioglan AB, Director Product & Technology Support Ferring A/S, Head of Process Development Ferring AB, cross functional roles within Process Development and Project Management at Astra AB, Kabi Pharmacia AB and ACO AB.

Current assignments: None.

Previous assignments (past five years): None.

Annika Andersson, QA/RA Director

Annika Andersson is a Biomedical Scientist from Malmö University. She has more than 25 years’ experience within the life science and diagnostics industry, with the main focus on regulatory affairs and quality assurance of in vitro diagnostic medical devices. Annika contributes with global experience within regulatory strategies and regulatory submissions of IVDs. Her track record includes leading successful regulatory approval processes of medical devices for IVD CE marking as well as IVD approvals in Canada, China, India, Japan, Korea, Mexico, Russia and 510(k) clearances in the USA.

Current assignments: None.

Previous assignments (past five years): Leading position at Euro Diagnostica AB (now SVAR Life Science AB).


Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form. Please check the junk mail if you cannot find the message.

Press releases
Financial reports